ADHD Medication and Psychosis: What the Evidence Shows
Psychosis is an uncommon but serious potential risk associated with stimulant medicines prescribed for ADHD. Research findings vary, and studies suggest the risk may differ between stimulant types. Health professionals advise thorough assessment, regular monitoring and following prescriptions.

Australian researchers say psychosis is an uncommon potential risk of stimulant medication for attention deficit hyperactivity disorder (ADHD), but studies have not established that the medicines cause it. The question of what's link between ADHD medication and psychosis matters to the growing number of Australians prescribed stimulants.
In 2023–24, just under 600,000 Australians were dispensed government-subsidized ADHD medicine, up from two in every 1,000 people in 2004–05 to 22 in every 1,000. Stimulants accounted for 87% of ADHD prescriptions in 2023–24.
Psychosis is a symptom, not a diagnosis. It can involve difficulty distinguishing what is real, including hearing or seeing things that are not there, and may require acute care.
Stimulants are the most common ADHD medicines prescribed in Australia. They include methylphenidate, sold under brands such as Ritalin and Concerta, and amphetamine medicines such as dexamfetamine and lisdexamfetamine, sold as Vyvanse.
These drugs boost dopamine and noradrenaline, neurotransmitters involved in reward, motivation and focus. Non-stimulant medicines, including atomoxetine, guanfacine and clonidine, are also prescribed but are less common.
Findings on psychosis risk vary. A review combining 16 studies of 390,000 people with ADHD found that 2.8% of those prescribed stimulants developed psychotic symptoms. Those symptoms do not necessarily mean a person developed a lasting disorder.
A US study of more than 220,000 teenagers and young adults starting stimulant treatment found about one in 660 developed psychosis in the months after beginning medication. In a Finnish study of nearly 4,000 young people prescribed methylphenidate, researchers found no relationship between the drug and increased psychosis risk.
Two population-based studies found psychosis was about twice as common with amphetamines as with methylphenidate. Researchers also said people with ADHD may have a higher risk of psychosis whether or not they take medication, making it difficult to separate the effects of the condition from those of treatment.
Stimulant treatment has also been linked to reduced ADHD symptoms, including impulsiveness and distractibility. The article’s authors said use was associated with lower risks of motor vehicle accidents, substance misuse, suicidal thoughts and behaviors, and criminal convictions.
They advised people seeking ADHD care to get a thorough, evidence-based assessment rather than relying on brief online questionnaires. Assessment may include developmental history, checks for other mental health concerns and information from people who know the patient.
Patients should follow their prescriptions, avoid changing doses without speaking to a doctor and check in regularly with health-care professionals, the authors said.
Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
Lifestyle7 Signs Your Social Battery Is Running Low (and Why You Keep Cancelling Plans)
Lifestyle · Food & HealthThanksgiving Food Safety: How Long Leftovers Last and the Safe Turkey Temperature
Lifestyle7 Quiet Habits of Emotionally Intelligent People, According to Psychologists
LifestylePeople Who Don’t Like Celebrating Their Birthday Often Share These 7 Traits




















